Andilum, Baby Girl .
HRN: 21-99-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/26/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
09/26/2022
10/09/2022
IV
5.4mg
Q48
Neonatal Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes